<PAGE> 1
EXHIBIT 99.1
Contact Information:
COFFIN COMMUNICATIONS GROUP PMR CORPORATION
15300 Ventura Boulevard, Suite 303 501 Washington Street, 5th Floor
Sherman Oaks, CA 91403 San Diego, CA 92103
(818) 789-0100 (619) 610-4001
Crocker Coulson, Partner Mark Clein, CEO
[email protected] Jean Dunn, Chief Financial Officer
FOR IMMEDIATE RELEASE
PMR ANNOUNCES SPECIAL DIVIDEND OF $1.00 PER SHARE
SAN DIEGO, CA, DECEMBER 14, 2000 -- PMR Corporation (NasdaqNM:PMRP), a leader in
the development of innovative market research solutions for the pharmaceutical
and healthcare industries, today announced that it will issue a special dividend
of $1.00 per share. The dividend will be payable on December 29, 2000 to
shareholders of record as of December 21, 2000. There are approximately
7,100,000 shares outstanding.
"The Company is constantly evaluating its cash needs while focussing on building
long-term shareholder value. The dividend payment reflects the Company's
commitment to its shareholders to maximize their investment," said Mark Clein,
CEO. "We are pleased with the progress of the InfoScriber subsidiary and we
intend to continue to manage the development of the business so that we have
sufficient resources to capitalize on this significant opportunity."
InfoScriber Corporation has developed a unique web-based platform that provides
real-time longitudinal and physician reasoning database information products to
the pharmaceutical and healthcare industry. PMR also manages programs and
services for individuals with a serious mental illness.
This press release contains forward looking statements that involve risks and
uncertainties, including the risk that the future financial impact from the
development of InfoScriber and the sufficiency of PMR's financial resources for
the expansion of this business will not be as expected; and the risks and
uncertainties set forth in PMR's periodic reports and other filings with the
Securities and Exchange Commission. Forward-looking statements reflect PMR's
current views with respect to future events. Actual results may vary materially
and adversely from those anticipated, believed, estimated or otherwise
indicated.
